News | March 2022

Announcing dQ&A’s First Look Insights Qualitative Research Service

We are excited and curious about the highly anticipated diabetes drugs, devices, and therapies launching in 2022. The future is bright, with many open questions for the diabetes industry.

  • What is the patient experience with just-launched diabetes products?
  • What causes people to try something new?
  • How could existing launches improve future roll outs?

The success of a launch can be heavily influenced by understanding the true impact that these products and services will have for the people that use them on a daily basis.

Our resident qualitative expert, Alice Morgan, has designed a groundbreaking data service with just this in mind.

We are excited to announce dQ&A’s new syndicated qualitative research service, First Look Insights, which will provide the earliest possible qualitative insights from authentic, real-world patient experiences with just-launched products, using structured and proven research techniques.

This new service will provide the First Look into how users experience recently-launched diabetes products. It will help to explain how well each product delivers its functional and emotional benefits to determine what works, and what needs more work.

Our first report will be coming out very soon. To understand the true impact that these products and services will have, drop us a line at

About dQ&A – The Diabetes Research Company

dQ&A is a social enterprise committed to making life better for people with diabetes. We harness patient voices to drive better business results and better health outcomes. For over 14 years, we have been comprehensively tracking the diabetes experience in the United States, Canada, and Europe. We are trusted by diabetes industry leaders for our independence, commitment, and expertise. Our team has decades of experience in quantitative and qualitative research with a deep knowledge of diabetes. We’re efficient and effective; our insights are actionable and accessible. To learn more, send us an email at For research highlights, visit us at and follow us on LinkedIn (dQ&A – The Diabetes Research Company)